The evolutionarily conserved presence of SAA proteins in colostrum establishes a potential role for these cytokine‐like proteins in neonatal host defense during a critical, early postnatal period and suggests possible therapeutic application(s) in conditions where exposure to these molecules may be limited (e.g. prematurity or malnutrition). This evidence concerns the gene SAA1 and nutritional deficiency disease.